Shengbin Pei
Impact in
-
- Cancer-related molecular mechanisms research
-
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
Papers in
-
- RNA modifications and cancer 6
- Single-cell and spatial transcriptomics 3
- RNA Research and Splicing 3
-
- Ferroptosis and cancer prognosis 10
- Co-authors
- Pengpeng Zhang (10 shared papers)Jiaheng Xie (6 shared papers)Wei Wang (3 shared papers)Jian-Lan Liu (3 shared papers)Yiqin Xia (5 shared papers)Fang Yang (1 shared paper)Hui Xie (2 shared papers)Xiao Zhang (1 shared paper)
- Journals
- Frontiers in Immunology (5 papers)Frontiers in Endocrinology (3 papers)Aging (2 papers)BMC Cancer (1 paper)The Breast (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Shengbin Pei
20 papers receiving 317 citations
Peers
Comparison fields: 5 of 44
- Cancer Research 130
- Oncology 138
- Immunology 90
- Pulmonary and Respiratory Medicine 122
- Molecular Biology 182
Countries citing papers authored by Shengbin Pei
This map shows the geographic impact of Shengbin Pei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengbin Pei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengbin Pei more than expected).
Fields of papers citing papers by Shengbin Pei
This network shows the impact of papers produced by Shengbin Pei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengbin Pei. The network helps show where Shengbin Pei may publish in the future.
Co-authors
The 25 scholars most cited alongside Shengbin Pei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 45 | |
| 2 | 2023 | 39 | |
| 3 | 2023 | 38 | |
| 4 | 2023 | 27 | |
| 5 | 2024 | 24 | |
| 6 | 2023 | 24 | |
| 7 | 2023 | 22 | |
| 8 | 2023 | 20 | |
| 9 | 2024 | 18 | |
| 10 | 2024 | 10 | |
| 11 | 2023 | 10 | |
| 12 | 2023 | 8 | |
| 13 | 2023 | 7 | |
| 14 | 2023 | 6 | |
| 15 | 2023 | 6 | |
| 16 | 2024 | 5 | |
| 17 | 2022 | 5 | |
| 18 | 2024 | 3 | |
| 19 | 2024 | 3 | |
| 20 | 2025 | 1 |
About Shengbin Pei
Shengbin Pei is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Immunology, having authored 24 papers that have together received 321 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (10 papers), Cancer Immunotherapy and Biomarkers (7 papers), RNA modifications and cancer (6 papers), Cancer Genomics and Diagnostics (5 papers), Single-cell and spatial transcriptomics (3 papers), RNA Research and Splicing (3 papers), Immune cells in cancer (3 papers) and Vascular Tumors and Angiosarcomas (2 papers). The work is most often cited by research in Cancer Research (130 citations), Oncology (138 citations), Immunology (90 citations), Pulmonary and Respiratory Medicine (122 citations) and Molecular Biology (182 citations). Shengbin Pei has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Pengpeng Zhang, Jiaheng Xie, Wei Wang, Jian-Lan Liu, Yiqin Xia, Fang Yang, Hui Xie, Xiao Zhang, Jun Li and Huilin Chen. Their work appears in journals such as Frontiers in Immunology, Frontiers in Endocrinology, Aging, BMC Cancer and The Breast.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.